Annual EBITDA
$3.75 M
+$31.82 M+113.36%
December 31, 2023
Summary
- As of February 7, 2025, TCON annual EBITDA is $3.75 million, with the most recent change of +$31.82 million (+113.36%) on December 31, 2023.
- During the last 3 years, TCON annual EBITDA has risen by +$19.98 million (+123.11%).
- TCON annual EBITDA is now at all-time high.
Performance
TCON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.91 M
+$296.00 K+9.24%
June 30, 2024
Summary
- As of February 7, 2025, TCON quarterly EBITDA is -$2.91 million, with the most recent change of +$296.00 thousand (+9.24%) on June 30, 2024.
- Over the past year, TCON quarterly EBITDA has dropped by -$3.32 million (-811.00%).
- TCON quarterly EBITDA is now -125.47% below its all-time high of $11.42 million, reached on September 30, 2023.
Performance
TCON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$5.71 M
-$6.51 M-53.26%
June 30, 2024
Summary
- As of February 7, 2025, TCON TTM EBITDA is $5.71 million, with the most recent change of -$6.51 million (-53.26%) on June 30, 2024.
- Over the past year, TCON TTM EBITDA has dropped by -$2.41 million (-29.70%).
- TCON TTM EBITDA is now -53.26% below its all-time high of $12.23 million, reached on March 31, 2024.
Performance
TCON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TCON EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.4% | -811.0% | -29.7% |
| 3 y3 years | +123.1% | +53.2% | +118.9% |
| 5 y5 years | +110.8% | +53.4% | +125.7% |
TCON EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.2% | -125.5% | +69.2% | -53.3% | +117.4% |
| 5 y | 5-year | at high | +113.2% | -125.5% | +69.2% | -53.3% | +117.4% |
| alltime | all time | at high | +110.8% | -125.5% | +73.1% | -53.3% | +116.5% |
TRACON Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$2.91 M(-9.2%) | $5.71 M(-53.3%) |
| Mar 2024 | - | -$3.20 M(-883.4%) | $12.23 M(+50.4%) |
| Dec 2023 | $3.75 M(-113.4%) | $409.00 K(-96.4%) | $8.13 M(+392.3%) |
| Sep 2023 | - | $11.42 M(+216.8%) | $1.65 M(-110.3%) |
| Jun 2023 | - | $3.60 M(-149.4%) | -$16.08 M(-37.9%) |
| Mar 2023 | - | -$7.30 M(+20.3%) | -$25.90 M(-7.6%) |
| Dec 2022 | -$28.07 M(-1.0%) | -$6.07 M(-3.9%) | -$28.05 M(-5.4%) |
| Sep 2022 | - | -$6.32 M(+1.6%) | -$29.64 M(-1.9%) |
| Jun 2022 | - | -$6.21 M(-34.2%) | -$30.21 M(-8.0%) |
| Mar 2022 | - | -$9.45 M(+23.3%) | -$32.84 M(+15.8%) |
| Dec 2021 | -$28.35 M(+74.7%) | -$7.66 M(+11.3%) | -$28.35 M(+14.0%) |
| Sep 2021 | - | -$6.88 M(-22.2%) | -$24.86 M(+13.9%) |
| Jun 2021 | - | -$8.85 M(+78.6%) | -$21.83 M(+26.2%) |
| Mar 2021 | - | -$4.96 M(+18.6%) | -$17.30 M(+6.6%) |
| Dec 2020 | -$16.23 M(-27.1%) | -$4.18 M(+8.5%) | -$16.23 M(+2.4%) |
| Sep 2020 | - | -$3.85 M(-10.7%) | -$15.85 M(-7.2%) |
| Jun 2020 | - | -$4.31 M(+11.0%) | -$17.08 M(-10.1%) |
| Mar 2020 | - | -$3.89 M(+2.2%) | -$19.00 M(-14.7%) |
| Dec 2019 | -$22.27 M(-35.8%) | -$3.80 M(-25.1%) | -$22.27 M(-15.0%) |
| Sep 2019 | - | -$5.08 M(-18.6%) | -$26.19 M(-13.2%) |
| Jun 2019 | - | -$6.24 M(-12.9%) | -$30.18 M(-10.4%) |
| Mar 2019 | - | -$7.16 M(-7.3%) | -$33.68 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$34.70 M(+91.0%) | -$7.72 M(-14.8%) | -$34.70 M(+4.1%) |
| Sep 2018 | - | -$9.07 M(-6.8%) | -$33.33 M(+45.8%) |
| Jun 2018 | - | -$9.73 M(+18.9%) | -$22.86 M(+17.5%) |
| Mar 2018 | - | -$8.18 M(+28.9%) | -$19.45 M(+7.1%) |
| Dec 2017 | -$18.17 M(-29.6%) | -$6.35 M(-553.4%) | -$18.16 M(+2.2%) |
| Sep 2017 | - | $1.40 M(-122.2%) | -$17.78 M(-28.2%) |
| Jun 2017 | - | -$6.32 M(-8.4%) | -$24.75 M(-6.3%) |
| Mar 2017 | - | -$6.90 M(+15.6%) | -$26.42 M(+2.4%) |
| Dec 2016 | -$25.80 M(+10.2%) | -$5.96 M(+7.0%) | -$25.80 M(-15.8%) |
| Sep 2016 | - | -$5.58 M(-30.2%) | -$30.65 M(-2.1%) |
| Jun 2016 | - | -$7.99 M(+27.4%) | -$31.29 M(+20.4%) |
| Mar 2016 | - | -$6.27 M(-42.0%) | -$26.00 M(+10.8%) |
| Dec 2015 | -$23.42 M(+279.9%) | -$10.82 M(+73.9%) | -$23.46 M(+57.1%) |
| Sep 2015 | - | -$6.22 M(+131.5%) | -$14.93 M(+43.5%) |
| Jun 2015 | - | -$2.69 M(-28.0%) | -$10.40 M(+21.0%) |
| Mar 2015 | - | -$3.73 M(+62.6%) | -$8.60 M(+39.5%) |
| Dec 2014 | -$6.16 M(-19.6%) | -$2.29 M(+35.6%) | -$6.16 M(+1.9%) |
| Sep 2014 | - | -$1.69 M(+91.6%) | -$6.05 M(+38.8%) |
| Jun 2014 | - | -$883.00 K(-31.8%) | -$4.36 M(+25.4%) |
| Mar 2014 | - | -$1.29 M(-40.6%) | -$3.48 M(+59.4%) |
| Dec 2013 | -$7.67 M(+55.9%) | -$2.18 M | -$2.18 M |
| Dec 2012 | -$4.92 M | - | - |
FAQ
- What is TRACON Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual EBITDA year-on-year change?
- What is TRACON Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly EBITDA year-on-year change?
- What is TRACON Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals TTM EBITDA year-on-year change?
What is TRACON Pharmaceuticals annual EBITDA?
The current annual EBITDA of TCON is $3.75 M
What is the all time high annual EBITDA for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual EBITDA is $3.75 M
What is TRACON Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, TCON annual EBITDA has changed by +$31.82 M (+113.36%)
What is TRACON Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of TCON is -$2.91 M
What is the all time high quarterly EBITDA for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly EBITDA is $11.42 M
What is TRACON Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, TCON quarterly EBITDA has changed by -$3.32 M (-811.00%)
What is TRACON Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of TCON is $5.71 M
What is the all time high TTM EBITDA for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high TTM EBITDA is $12.23 M
What is TRACON Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, TCON TTM EBITDA has changed by -$2.41 M (-29.70%)